Acuta Capital Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-250,000	Closed	-$27.9M	–	57
2020 Q3	$27.9M	Buy	+250,000	New	+$28M	7.57%	3
2020 Q1	–	Sell	-500,000	Closed	-$47.6M	–	39
2019 Q4	$47.6M	Buy	500,000 +350,000	+233%	+$30.3M	11.78%	2
2019 Q3	$11.4M	Sell	150,000 -50,000	-25%	-$4.16M	8.26%	4
2019 Q2	$17.5M	Buy	+200,000	New	+$17.1M	6.24%	2
2019 Q1	–	Sell	-100,000	Closed	-$7.17M	–	35
2018 Q4	$7.17M	Hold	100,000	–	–	5.47%	5
2018 Q3	$9.59M	Hold	100,000	–	–	3.42%	10
2018 Q2	$9.52M	Sell	100,000 -400,000	-80%	-$36.8M	1.69%	16
2018 Q1	$43.9M	Buy	500,000 +150,000	+43%	+$13.7M	7.16%	4
2017 Q4	$29.7M	Sell	350,000 -210,000	-38%	-$17.6M	5.61%	5
2017 Q3	$48.5M	Buy	560,000 +177,700	+46%	+$14.2M	8.69%	3
2017 Q2	$29.5M	Sell	382,300 -347,700	-48%	-$24.7M	8.26%	2
2017 Q1	$50.6M	Buy	+730,000	New	+$49M	12%	1
2016 Q4	–	Sell	-150,000	Closed	-$9.94M	–	66
2016 Q3	$9.94M	Buy	+150,000	New	+$9.28M	3.73%	7
2016 Q1	–	Sell	-80,000	Closed	-$5.62M	–	54
2015 Q4	$5.62M	Buy	80,000 +10,000	+14%	+$682K	2.69%	14
2015 Q3	$4.36M	Buy	+70,000	New	+$5.52M	2.52%	9